Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary ciliary dyskinesia cases bronchoscopic sampling and TEM analysis: sampling & diagnosis in PCD.

Ultrastructural pathology·2025
Same author

Importance of mediastinal granulomatous/sarcoid-like lymphadenopathy in extrathoracic malignancies.

Diagnostic cytopathology·2024
Same author

A patient with widespread skin lesions presenting with massive pleural effusion.

Tuberkuloz ve toraks·2023
Same author

What is your diagnosis?

Journal of the Turkish German Gynecological Association·2022
Same author

Allergic bronchopulmonary aspergillosis with endobronchial signs: Two cases.

Tuberkuloz ve toraks·2022
Same author

A new device for bronchoscopy for better protection.

Turkish journal of medical sciences·2022
Same journal

Treatment of severe tracheobronchopathia osteochondroplastica: Application of endobronchial argon plasma coagulation, presentation of three cases and literature review.

Tuberkuloz ve toraks·2026
Same journal

Fractional exhaled nitric oxide and practical points in asthma diagnosis and management.

Tuberkuloz ve toraks·2026
Same journal

High-resolution CT findings of culture-confirmed enterococcal pneumonia: A two-center retrospective study.

Tuberkuloz ve toraks·2026
Same journal

Explainable benchmarking of U-Net variants for lung segmentation on chest radiographs.

Tuberkuloz ve toraks·2026
Same journal

Short-term changes in serum total protein and albumin and clinical outcomes in acute exacerbation of interstitial lung diseases.

Tuberkuloz ve toraks·2026
Same journal

Successful and practical pirfenidone desensitization.

Tuberkuloz ve toraks·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

[Hypersensitivity pneumonitis].

Elif Küpeli1, Demet Karnak

  • 1Department of Chest Diseases, Faculty of Medicine, Baskent University, Ankara, Turkey. elifkupeli@yahoo.com

Tuberkuloz Ve Toraks
|July 12, 2011
PubMed
Summary
This summary is machine-generated.

Hypersensitivity pneumonitis is an immune-mediated lung disease from inhaling specific agents. This review covers its varied clinical presentations and characteristics based on current literature.

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Related Experiment Videos

Last Updated: May 31, 2026

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Area of Science:

  • Immunology
  • Pulmonology
  • Environmental Medicine

Context:

  • Hypersensitivity pneumonitis (HP) is a complex lung disease.
  • It arises from repeated inhalation of environmental antigens in susceptible individuals.
  • HP presents a wide spectrum of clinical manifestations.

Purpose:

  • To review the key characteristics of hypersensitivity pneumonitis.
  • To consolidate current understanding of HP based on available literature.
  • To provide an overview of the factors influencing HP presentation.

Summary:

  • HP is an immunologically induced lung condition.
  • Clinical presentation varies based on inhaled agent, exposure levels, and host immune response.
  • This review synthesizes existing knowledge on HP characteristics.

Impact:

  • Enhances understanding of hypersensitivity pneumonitis.
  • Provides a foundation for further research into HP.
  • Aids clinicians in diagnosing and managing HP.